In all, the final Monday of 2025 looked less like the start of a new narrative and more like a tidy epilogue: investors trimming winners, testing how far tariffs and higher real rates can bend the expansion without breaking it, and quietly…
The “Doomsday Glacier” is edging closer to a dangerous tipping point, but the story is less asteroid-strike apocalypse and more slow‑motion bond crisis: the numbers are sobering, the timeline is long, and there is still room for adults in the room to…
Nvidia’s (NVDA) $20 billion deal with Groq is less a moonshot than a balance‑sheet flex, underscoring how the chip giant is turning raw cash into an even wider moat around the AI data center kingdom. In classic Nvidia fashion, the company managed…
Gold and silver have turned 2025 into a full‑metal bull market, with bullion, miners, and ETFs all behaving as if the 1970s called and wants its rally back. GLD and SIL are riding that wave, and the NYSE’s big gold‑and‑silver producers are…
Wall Street tiptoed into the final holiday stretch with a Santa Claus rally that felt more like a well‑tailored cashmere sweater than an ugly Christmas jumper: comfortable but not euphoric. Major U.S. indexes ground higher over the week ending Friday, December 26,…
Artificial intelligence turned 2025 into a wealth factory, minting more than 50 new billionaires and reshaping the upper decks of the three‑comma club with the efficiency of a well‑tuned recommendation algorithm. The AI boom didn’t just pad existing fortunes—it drafted a new…
Wall Street tiptoed into the Christmas break with its party hat still firmly on, as major indexes notched fresh records or near-record closes in a holiday‑shortened session that felt more champagne than coal. In all, Christmas Eve gave investors what they wanted…
Wall Street tiptoed into the holiday break on Tuesday with the air of a market that has already opened its presents and is now just admiring the wrapping paper. Stocks drifted rather than surged, but under the surface, big tech, nuclear hopefuls…
Radiopharmaceuticals are quietly becoming the part of oncology that no longer sits in the hospital basement—capital, M&A desks, and regulators have all joined the tour. For investors, the space now looks less like a scientific hobby and more like a pipeline strategy…
Wall Street opened the final Christmas week of 2025 in a festive mood, with equities drifting higher in to record territory as if trying on a Santa rally for size without quite committing to the full costume, however the smalls seem to…